ERO1A-Q4 was also associated with poor prognosis in both squamous (HR = 1.22) and adenocarcinoma (HR = 1.51) histology, with a median difference in survival of 4.4 m and 13.3 m, respectively (Fig. 1B, C). The gene discussed is ERO1A; the disease is adenocarcinoma.